NABP vs. URAC Specialty Pharmacy Accreditation — Which Do You Need?
Last updated: April 2026
Specialty pharmacies seeking Optum Rx network access need NABP accreditation — it is a contractual requirement, not a preference. Specialty pharmacies prioritizing clinical quality credentialing for health plan contracting need URAC. For pharmacies with diversified PBM contracts, dual accreditation is the optimal strategy: 750 specialty pharmacy locations currently hold multiple accreditations simultaneously.
No neutral, comprehensive comparison of NABP and URAC specialty pharmacy accreditation standards exists in the public domain. This page fills that gap — drawing on both programs' published standards and IHS's consulting experience across both bodies.
The One-Paragraph Answer
NABP and URAC are built on different philosophies. NABP functions as a regulatory enforcement and verification body — its accreditation confirms legal compliance, drug supply chain security, and dispensing accuracy. URAC is a quality improvement organization — its accreditation confirms clinical quality management, patient outcome measurement, and care coordination. In PBM terms: Optum Rx requires NABP. Most other major PBMs accept either. If your operations depend on Optum Rx network participation, NABP is non-negotiable. If your goal is broad health plan credentialing, URAC is the stronger signal. IHS is the only URAC-certified accreditation consulting firm in the United States — and the only firm with simultaneous expertise in both programs.
Side-by-Side Comparison
| Criteria | NABP Specialty Pharmacy Accreditation | URAC Specialty Pharmacy Accreditation |
|---|---|---|
| Accrediting Body | National Association of Boards of Pharmacy (NABP) | URAC (formerly Utilization Review Accreditation Commission) |
| Primary Philosophy | Regulatory enforcement and verification — legal compliance, drug supply chain security, dispensing accuracy | Clinical quality improvement — patient outcomes, care coordination, measurable quality metrics |
| Standards Scope | Section ACC (Accreditation Standards) and Section PHY (Pharmacy Standards); annual review cycle each January | Specialty Pharmacy core standards plus applicable module standards; multi-year revision cycles with stakeholder comment periods |
| Accreditation Term | 3 years with annual compliance reviews in years 2 and 3 | 3 years with periodic on-site and desk reviews |
| NABP Fees (DDA) | $12,500 total 3-year NABP fee (effective December 18, 2024); Specialty Pharmacy Accreditation fees separate — see nabp.pharmacy | N/A |
| URAC Fees | N/A | Application and survey fees vary by organization size; contact URAC directly for current schedule |
| IHS Consulting Cost Range | $19,000–$49,000+ depending on size and complexity | $19,000–$49,000+ depending on size and complexity |
| Typical Timeline | 6–9 months from engagement to award | 6–12 months from engagement to award depending on standards maturity |
| Patient Management Focus | Process completeness: complete profiles, DUR documentation, written education records, welcome kit tracking (PHY.F) | Clinical outcomes: disease-specific outcome measures, patient satisfaction, prescriber care coordination, quality improvement programs |
| Drug Supply Chain Standards | Strong — DSCSA compliance, source verification, controlled substance security, temperature monitoring (ACC.F) | Addressed but not the primary emphasis; supply chain requirements less granular than NABP |
| Personnel Requirements | Pre-hire vetting, initial training documentation, ongoing competency evaluations at required frequencies (ACC.D) | Staff qualifications, ongoing training, competency assessment, clinical staff credentialing |
| Quality Improvement Program | Policies and procedures must address quality improvement; less prescriptive on outcome measurement methodology | Formal quality management program required with outcome metrics, benchmarking, and documented improvement cycles |
| On-Site Survey Format | Announced, two-day comprehensive facility survey by registered pharmacist or compliance expert | Announced on-site survey; format varies by accreditation module and organization size |
| State Recognition | Indiana, Maryland, North Dakota, Wyoming require DDA by statute; Ohio integrating; broad state board recognition | Recognized by state health departments and health plans for quality credentialing; not typically integrated into state drug distribution licensure |
| PBM Network Requirement | Required by Optum Rx for Specialty Pharmacy Network participation | Accepted by multiple major PBMs for specialty pharmacy network tiers |
| Digital Advertising / Payments | NABP Healthcare Merchant Accreditation required by Google, Bing, Visa, Mastercard (separate program) | Not applicable |
| Wholesale Distribution | NABP DDA program covers wholesale distributors, 3PLs, 503B facilities, reverse distributors | Not applicable to wholesale drug distribution |
| Current Holders (US) | ~80 specific dispensing locations hold NABP Specialty Pharmacy Accreditation | Hundreds of specialty pharmacy locations — URAC is the more widely held specialty pharmacy credential |
| Dual Accreditation | 750 specialty pharmacy locations currently hold multiple accreditations simultaneously. IHS structures dual-accreditation engagements using shared documentation to minimize redundant work. | |
Sources: Access Market Intelligence, 2025; LighthouseAI, 2024; NABP 2026
When to Choose NABP Specialty Pharmacy Accreditation
NABP is the right first choice when your business objective is tied to regulatory compliance, supply chain verification, or specific PBM network contracts that name NABP explicitly.
Choose NABP When:
- You need Optum Rx network access. Optum Rx requires NABP Specialty Pharmacy Accreditation for participation in its Specialty Pharmacy Network. This is a contractual requirement — URAC accreditation does not satisfy it.
- You are a wholesale drug distributor in a mandate state. Indiana, Maryland, North Dakota, and Wyoming require NABP DDA by statute for wholesale distribution licenses. Ohio is increasingly integrating DDA into core licensure. In these states, NABP DDA is not optional.
- You operate an online or mail-order pharmacy. NABP Digital Pharmacy Accreditation (formerly VIPPS) is the recognized trust credential for internet pharmacies. Healthcare Merchant Accreditation is required by Google, Bing, Visa, and Mastercard for digital operations.
- Your primary concern is drug supply chain security and DSCSA compliance. NABP's standards are the most rigorous in the market for supply chain documentation — source verification, carrier vetting, temperature monitoring, and DEA records.
- You are a 503B outsourcing facility or 3PL. NABP has specific pathways for these nontraditional entities; URAC does not have equivalent programs.
- You operate in a state where NABP DDA is being integrated into wholesale licensure. Ohio's trend toward DDA integration makes early accreditation a strategic position for distributors anticipating future mandates.
When to Choose URAC Specialty Pharmacy Accreditation
URAC is the stronger credential when your business objective is clinical quality credentialing for health plan contracting, demonstrating patient outcome measurement capability, or differentiation in markets where clinical performance is the primary network selection criterion.
Choose URAC When:
- Your primary goal is health plan contracting. URAC's quality improvement framework is recognized by health plans as a clinical quality credential. For pharmacies seeking preferred tier status with health plans that reward quality outcomes, URAC is the more relevant signal.
- You serve health-system specialty pharmacy markets. Health systems evaluating specialty pharmacy partners often require or strongly prefer URAC accreditation as evidence of clinical quality management capability.
- Your PBM contracts do not specifically require NABP. Most major PBMs accept NABP, URAC, or ACHC for specialty pharmacy network participation. If Optum Rx is not in your contract target set, URAC may satisfy your network requirements with a lower operational burden.
- You are seeking limited distribution drug access from manufacturers. Some pharmaceutical manufacturers use URAC accreditation as a baseline qualification criterion for access to limited distribution drug programs.
- Clinical differentiation is your competitive strategy. In markets where multiple accredited pharmacies compete for the same patients, URAC's clinical quality framework provides a more meaningful basis for differentiation than regulatory compliance verification.
IHS is the only URAC-certified accreditation consulting firm in the United States. See our URAC Specialty Pharmacy Accreditation consulting page for the full URAC service overview.
Can You Get Both? Dual NABP and URAC Accreditation
Yes — and for pharmacies with diversified PBM contracts and health plan relationships, dual accreditation is the optimal strategy. 750 specialty pharmacy locations currently hold multiple accreditations simultaneously, according to Access Market Intelligence (2025).
Why Dual Accreditation Works
NABP and URAC standards overlap meaningfully in several operational domains: personnel qualification and training requirements, SOP framework requirements, facility and safety standards, patient management process documentation, and DUR system requirements. A pharmacy that has documented its operations to NABP's standard has already satisfied many of URAC's operational requirements. The incremental burden of adding URAC after NABP — or vice versa — is significantly lower than the sum of two independent accreditation processes.
How IHS Structures Dual-Accreditation Engagements
IHS maps both NABP and URAC standards against your operations in the initial gap analysis, identifying which documentation serves both programs and which requires program-specific development. We sequence surveys to minimize the period during which your staff is managing two simultaneous accreditation timelines. The result: dual accreditation for a total consulting investment that is materially less than two separate engagements billed at full rate.
IHS is the only URAC-certified consulting firm with simultaneous active expertise in NABP programs. That cross-program knowledge is not available at firms that specialize in one body.
Market Context: Why Accreditation Matters More Now
The specialty pharmacy accreditation landscape is growing in urgency for three converging reasons:
- State mandate expansion. Indiana, Maryland, North Dakota, and Wyoming already require NABP DDA for wholesale distribution licenses. Ohio is integrating DDA. California AB 1503 (effective July 1, 2026) adds PIC licensure requirements for national pharmacies. North Carolina HB 163 (pending) would force PBM recognition of NABP, URAC, or ACHC accreditation.
- PBM network consolidation. As PBM networks become more selective, accreditation is increasingly a baseline requirement for network participation rather than a differentiator. Pharmacies without accreditation face network exclusion — not just competitive disadvantage.
- DSCSA enforcement escalation. Full interoperable electronic track-and-trace enforcement is in effect, with ongoing escalation. NABP DDA is the strongest signal to trading partners and regulators of DSCSA compliance capability.
The specialty pharmacy accreditation services market was valued at $1.27 billion in 2024 and is projected to reach $2.28 billion by 2033 at a 6.8% CAGR. US specialty pharmaceutical dispensing reached $265 billion in 2024. Sources: Growth Market Reports, 2024; Drug Channels Institute, 2025
Frequently Asked Questions
Is NABP or URAC better for specialty pharmacy accreditation?
Neither is universally better — they serve different purposes and satisfy different PBM network requirements. Optum Rx requires NABP. Most other major PBMs accept either. For pharmacies with diversified PBM contracts, dual accreditation is the optimal strategy. IHS advises on the right sequencing based on your specific contract portfolio and market objectives — not on which program we find easier to consult.
What is the main philosophical difference between NABP and URAC?
NABP operates as a regulatory enforcement and verification body — its accreditation confirms legal compliance, supply chain security, and operational accuracy. URAC is a quality improvement organization — its accreditation confirms clinical quality management and measurable patient outcomes. NABP answers "Is this pharmacy operating legally and safely?" URAC answers "Is this pharmacy delivering high-quality clinical care?" Sources: PharmaTimes; Pharmacy Times
Can a specialty pharmacy hold both NABP and URAC accreditation?
Yes. 750 specialty pharmacy locations currently hold multiple accreditations simultaneously. Dual accreditation is a sound strategy for pharmacies whose PBM contract portfolio spans both Optum Rx (NABP-required) and health plans or PBMs that recognize URAC. IHS structures dual-accreditation engagements to use shared documentation and staggered survey timelines to minimize total burden.
Which PBMs require NABP vs. URAC?
Optum Rx requires NABP Specialty Pharmacy Accreditation for its Specialty Pharmacy Network. Other major PBM network requirements vary by contract tier and must be verified against your specific PBM agreements. IHS reviews your contracts as part of every accreditation strategy engagement. Source: NABP blog
How do NABP and URAC accreditation costs compare?
NABP DDA three-year fees total $12,500 (effective December 18, 2024). NABP Specialty Pharmacy Accreditation fees are separate — see nabp.pharmacy for current schedule. URAC specialty pharmacy fees vary by organization size. IHS consulting fees for either program range from approximately $19,000 to $49,000 or more depending on organizational size and documentation maturity. Dual-accreditation engagements with IHS are more cost-efficient than two separate full-rate engagements because shared documentation work is not duplicated.
Which accreditation should a specialty pharmacy pursue first?
The answer depends on your PBM contract priorities. If Optum Rx network access is your immediate goal, pursue NABP first — it is a contractual requirement. If your goal is health plan credentialing, pursue URAC first. If both are equally important, IHS structures dual-accreditation engagements that build documentation toward both programs concurrently, with staggered survey timelines to minimize burden.
How do NABP and URAC differ in patient management standards?
NABP's patient management standards (PHY.F) focus on operational completeness: complete patient profiles with diagnosis codes and medication histories, documented DUR cross-referencing, written patient education records, and welcome kit tracking. URAC's patient management standards require clinical depth: disease-specific outcome measures, patient satisfaction tracking, care coordination documentation with prescribers, and quality improvement programs based on outcome data. NABP verifies that patient management processes are in place. URAC verifies that those processes produce measurable clinical results.
Not Sure Which You Need? Schedule a Consultation.
IHS is the only URAC-certified accreditation consulting firm in the United States — and the only firm advising on NABP, URAC, ACHC, and Joint Commission programs simultaneously. We start every engagement by reviewing your PBM contracts, state distribution footprint, and organizational profile to identify the right accreditation path before you invest in the process.